{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T22:15:37Z","timestamp":1793657737302,"version":"4.5.1"},"reference-count":77,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T00:00:00Z","timestamp":1768435200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T00:00:00Z","timestamp":1770681600000},"content-version":"vor","delay-in-days":26,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Respir Res"],"DOI":"10.1186\/s12931-025-03465-6","type":"journal-article","created":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T05:32:52Z","timestamp":1768455172000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Immune dysregulation triggered by inflammatory cytokines in patients with severe respiratory infections"],"prefix":"10.1186","volume":"27","author":[{"given":"Jingwei","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shufan","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yalun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiayang","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changshu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiadi","family":"Gan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weimin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengdi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,15]]},"reference":[{"issue":"8","key":"3465_CR1","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1056\/NEJMoa2001017","volume":"382","author":"N Zhu","year":"2020","unstructured":"Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, et al. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med. 2020;382(8):727\u201333.","journal-title":"N Engl J Med"},{"key":"3465_CR2","unstructured":"Coronavirus disease (COVID-19) pandemic. 2025. Available from: https:\/\/www.who.int\/emergencies\/diseases\/novel-coronavirus-2019."},{"issue":"5","key":"3465_CR3","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1038\/s41577-020-0308-3","volume":"20","author":"X Cao","year":"2020","unstructured":"Cao X. COVID-19: immunopathology and its implications for therapy. Nat Rev Immunol. 2020;20(5):269\u201370.","journal-title":"Nat Rev Immunol"},{"issue":"10223","key":"3465_CR4","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","volume":"395","author":"C Huang","year":"2020","unstructured":"Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497\u2013506.","journal-title":"Lancet"},{"issue":"4","key":"3465_CR5","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1016\/S2213-2600(20)30076-X","volume":"8","author":"Z Xu","year":"2020","unstructured":"Xu Z, Shi L, Wang Y, Zhang J, Huang L, Zhang C, et al. Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Respir Med. 2020;8(4):420\u20132.","journal-title":"Lancet Respir Med"},{"issue":"6585","key":"3465_CR6","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1126\/science.abm8108","volume":"375","author":"M Merad","year":"2022","unstructured":"Merad M, Blish CA, Sallusto F, Iwasaki A. The immunology and immunopathology of COVID-19. Science. 2022;375(6585):1122\u20137.","journal-title":"Science"},{"issue":"1","key":"3465_CR7","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1038\/s41392-023-01640-z","volume":"8","author":"J Li","year":"2023","unstructured":"Li J, Zhou Y, Ma J, Zhang Q, Shao J, Liang S, et al. The long-term health outcomes, pathophysiological mechanisms and multidisciplinary management of long COVID. Signal Transduct Target Ther. 2023;8(1):416.","journal-title":"Signal Transduct Target Ther"},{"issue":"2","key":"3465_CR8","doi-asserted-by":"publisher","first-page":"pbac014","DOI":"10.1093\/pcmedi\/pbac014","volume":"5","author":"M Yang","year":"2022","unstructured":"Yang M, Lin C, Wang Y, Chen K, Han Y, Zhang H, et al. Cytokine storm promoting T cell exhaustion in severe COVID-19 revealed by single cell sequencing data analysis. Precis Clin Med. 2022;5(2):pbac014.","journal-title":"Precis Clin Med"},{"issue":"1","key":"3465_CR9","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.immuni.2020.06.017","volume":"53","author":"N Mangalmurti","year":"2020","unstructured":"Mangalmurti N, Hunter CA. Cytokine storms: understanding COVID-19. Immunity. 2020;53(1):19\u201325.","journal-title":"Immunity"},{"issue":"7865","key":"3465_CR10","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1038\/s41586-021-03569-1","volume":"595","author":"JC Melms","year":"2021","unstructured":"Melms JC, Biermann J, Huang H, Wang Y, Nair A, Tagore S, et al. A molecular single-cell lung atlas of lethal COVID-19. Nature. 2021;595(7865):114\u20139.","journal-title":"Nature"},{"key":"3465_CR11","first-page":"916","volume":"185(5)","author":"COvid-19 Multi-omics Blood ATlas (COMBAT) Consortium","year":"2022","unstructured":"COvid-19 Multi-omics Blood ATlas (COMBAT) consortium. A blood atlas of COVID-19 defines hallmarks of disease severity and specificity. Cell. 2022;185(5):916-938.e58.","journal-title":"Cell"},{"issue":"6","key":"3465_CR12","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1016\/j.cell.2020.08.001","volume":"182","author":"J Schulte-Schrepping","year":"2020","unstructured":"Schulte-Schrepping J, Reusch N, Paclik D, Ba\u00dfler K, Schlickeiser S, Zhang B, et al. Severe COVID-19 is marked by a dysregulated myeloid cell compartment. Cell. 2020;182(6):1419\u201340.e23.","journal-title":"Cell"},{"issue":"3","key":"3465_CR13","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1038\/s41590-024-02072-9","volume":"26","author":"A Zhu","year":"2025","unstructured":"Zhu A, Chen Z, Yan Q, Jiang M, Liu X, Li Z, et al. Robust mucosal SARS-CoV-2-specific T cells effectively combat COVID-19 and establish polyfunctional resident memory in patient lungs. Nat Immunol. 2025;26(3):459\u201372.","journal-title":"Nat Immunol"},{"issue":"5","key":"3465_CR14","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1038\/s41590-025-02135-5","volume":"26","author":"Y Gao","year":"2025","unstructured":"Gao Y, Cai C, Adamo S, Biteus E, Kamal H, Dager L, et al. Identification of soluble biomarkers that associate with distinct manifestations of long COVID. Nat Immunol. 2025;26(5):692\u2013705.","journal-title":"Nat Immunol"},{"issue":"7896","key":"3465_CR15","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1038\/s41586-021-04345-x","volume":"602","author":"M Yoshida","year":"2022","unstructured":"Yoshida M, Worlock KB, Huang N, Lindeboom RGH, Butler CR, Kumasaka N, et al. Local and systemic responses to SARS-CoV-2 infection in children and adults. Nature. 2022;602(7896):321\u20137.","journal-title":"Nature"},{"issue":"1","key":"3465_CR16","doi-asserted-by":"publisher","first-page":"108590","DOI":"10.1016\/j.celrep.2020.108590","volume":"34","author":"C Yao","year":"2021","unstructured":"Yao C, Bora SA, Parimon T, Zaman T, Friedman OA, Palatinus JA, et al. Cell-type-specific immune dysregulation in severely ill COVID-19 patients. Cell Rep. 2021;34(1):108590.","journal-title":"Cell Rep"},{"issue":"5","key":"3465_CR17","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1016\/j.cell.2020.10.001","volume":"183","author":"BJ Meckiff","year":"2020","unstructured":"Meckiff BJ, Ram\u00edrez-Su\u00e1stegui C, Fajardo V, Chee SJ, Kusnadi A, Simon H, et al. Imbalance of regulatory and cytotoxic SARS-CoV-2-reactive CD4(+) T cells in COVID-19. Cell. 2020;183(5):1340\u201353.e16.","journal-title":"Cell"},{"issue":"1","key":"3465_CR18","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1038\/s41467-022-28505-3","volume":"13","author":"JM Amrute","year":"2022","unstructured":"Amrute JM, Perry AM, Anand G, Cruchaga C, Hock KG, Farnsworth CW, et al. Cell specific peripheral immune responses predict survival in critical COVID-19 patients. Nat Commun. 2022;13(1):882.","journal-title":"Nat Commun"},{"issue":"5","key":"3465_CR19","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1038\/s41556-021-00681-2","volume":"23","author":"M Saichi","year":"2021","unstructured":"Saichi M, Ladjemi MZ, Korniotis S, Rousseau C, Ait Hamou Z, Massenet-Regad L, et al. Single-cell RNA sequencing of blood antigen-presenting cells in severe COVID-19 reveals multi-process defects in antiviral immunity. Nat Cell Biol. 2021;23(5):538\u201351.","journal-title":"Nat Cell Biol"},{"issue":"6738","key":"3465_CR20","doi-asserted-by":"publisher","first-page":"eadq2509","DOI":"10.1126\/science.adq2509","volume":"387","author":"X Wei","year":"2025","unstructured":"Wei X, Qian W, Narasimhan H, Chan T, Liu X, Arish M, et al. Macrophage peroxisomes guide alveolar regeneration and limit SARS-CoV-2 tissue sequelae. Science. 2025;387(6738):eadq2509.","journal-title":"Science"},{"issue":"6756","key":"3465_CR21","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1126\/science.adi8828","volume":"389","author":"DA Hoagland","year":"2025","unstructured":"Hoagland DA, Rodr\u00edguez-Morales P, Mann AO, Baez Vazquez AY, Yu S, Lai A, et al. Macrophage-derived oncostatin M repairs the lung epithelial barrier during inflammatory damage. Science. 2025;389(6756):169\u201375.","journal-title":"Science"},{"issue":"6585","key":"3465_CR22","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1126\/science.abn1755","volume":"375","author":"DM Altmann","year":"2022","unstructured":"Altmann DM, Boyton RJ. COVID-19 vaccination: the road ahead. Science. 2022;375(6585):1127\u201332.","journal-title":"Science"},{"issue":"4","key":"3465_CR23","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.pccm.2023.11.001","volume":"1","author":"J Huang","year":"2023","unstructured":"Huang J, Huang L, Xi J, Li Y, Zhou J, Bao Z, et al. Risk of extended viral shedding of Omicron BA.2 in shanghai: implications for vaccination strategy optimization. Chin Med J Pulm Crit Care Med. 2023;1(4):241\u20138.","journal-title":"Chin Med J Pulm Crit Care Med"},{"issue":"11","key":"3465_CR24","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1056\/NEJMra2206573","volume":"387","author":"DH Barouch","year":"2022","unstructured":"Barouch DH. Covid-19 vaccines - immunity, variants, boosters. N Engl J Med. 2022;387(11):1011\u2013120.","journal-title":"N Engl J Med"},{"key":"3465_CR25","first-page":"100134","volume":"6","author":"KJ Bruxvoort","year":"2022","unstructured":"Bruxvoort KJ, Sy LS, Qian L, Ackerson BK, Luo Y, Lee GS, et al. Real-world effectiveness of the mRNA-1273 vaccine against COVID-19: interim results from a prospective observational cohort study. Lancet Reg Health Am. 2022;6:100134.","journal-title":"Lancet Reg Health Am"},{"issue":"27","key":"3465_CR26","doi-asserted-by":"publisher","first-page":"2603","DOI":"10.1056\/NEJMoa2034577","volume":"383","author":"FP Polack","year":"2020","unstructured":"Polack FP, Thomas SJ, Kitchin N, Absalon J, Gurtman A, Lockhart S, et al. Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine. N Engl J Med. 2020;383(27):2603\u201315.","journal-title":"N Engl J Med"},{"issue":"10277","key":"3465_CR27","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1016\/S0140-6736(21)00432-3","volume":"397","author":"M Voysey","year":"2021","unstructured":"Voysey M, Costa Clemens SA, Madhi SA, Weckx LY, Folegatti PM, Aley PK, et al. Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials. Lancet. 2021;397(10277):881\u201391.","journal-title":"Lancet"},{"issue":"1","key":"3465_CR28","doi-asserted-by":"publisher","first-page":"10778","DOI":"10.1038\/s41467-024-55087-z","volume":"15","author":"J Yang","year":"2024","unstructured":"Yang J, Hong W, Shi H, He C, Lei H, Zhou Y, et al. Trivalent recombinant protein vaccine induces cross-neutralization against XBB lineage and JN.1 subvariants: preclinical and phase 1 clinical trials. Nat Commun. 2024;15(1):10778.","journal-title":"Nat Commun"},{"issue":"1","key":"3465_CR29","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1038\/s41392-025-02139-5","volume":"10","author":"J Yang","year":"2025","unstructured":"Yang J, He X, Shi H, He C, Lei H, He H, et al. Recombinant XBB.1.5 boosters induce robust neutralization against KP.2- and KP.3-included JN.1 sublineages. Signal Transduct Target Ther. 2025;10(1):47.","journal-title":"Signal Transduct Target Ther"},{"issue":"1","key":"3465_CR30","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1038\/s41392-025-02154-6","volume":"10","author":"J Yang","year":"2025","unstructured":"Yang J, Hong W, Shi H, Wang Z, He C, Lei H, et al. A recombinant protein vaccine induces protective immunity against SARS-CoV-2 JN.1 and XBB-lineage subvariants. Signal Transduct Target Ther. 2025;10(1):58.","journal-title":"Signal Transduct Target Ther"},{"issue":"7","key":"3465_CR31","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1038\/nmeth.3865","volume":"13","author":"Y Mostovoy","year":"2016","unstructured":"Mostovoy Y, Levy-Sakin M, Lam J, Lam ET, Hastie AR, Marks P, et al. A hybrid approach for de novo human genome sequence assembly and phasing. Nat Methods. 2016;13(7):587\u201390.","journal-title":"Nat Methods"},{"issue":"4","key":"3465_CR32","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.cels.2019.03.003","volume":"8","author":"CS McGinnis","year":"2019","unstructured":"McGinnis CS, Murrow LM, Gartner ZJ. DoubletFinder: doublet detection in single-cell RNA sequencing data using artificial nearest neighbors. Cell Syst. 2019;8(4):329\u201337.e24.","journal-title":"Cell Syst"},{"issue":"12","key":"3465_CR33","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1038\/s41592-019-0619-0","volume":"16","author":"I Korsunsky","year":"2019","unstructured":"Korsunsky I, Millard N, Fan J, Slowikowski K, Zhang F, Wei K, et al. Fast, sensitive and accurate integration of single-cell data with harmony. Nat Methods. 2019;16(12):1289\u201396.","journal-title":"Nat Methods"},{"issue":"1","key":"3465_CR34","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1038\/nbt.4314","volume":"37","author":"E Becht","year":"2019","unstructured":"Becht E, McInnes L, Healy J, Dutertre C-A, Kwok IWH, Ng LG, et al. Dimensionality reduction for visualizing single-cell data using UMAP. Nat Biotechnol. 2019;37(1):38\u201344.","journal-title":"Nat Biotechnol"},{"issue":"8057","key":"3465_CR35","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1038\/s41586-025-08592-0","volume":"640","author":"M Feuermann","year":"2025","unstructured":"Feuermann M, Mi H, Gaudet P, Muruganujan A, Lewis SE, Ebert D, et al. A compendium of human gene functions derived from evolutionary modelling. Nature. 2025;640(8057):146\u201354.","journal-title":"Nature"},{"issue":"11","key":"3465_CR36","doi-asserted-by":"publisher","first-page":"3292","DOI":"10.1038\/s41596-024-01020-z","volume":"19","author":"S Xu","year":"2024","unstructured":"Xu S, Hu E, Cai Y, Xie Z, Luo X, Zhan L, et al. Using clusterProfiler to characterize multiomics data. Nat Protoc. 2024;19(11):3292\u2013320.","journal-title":"Nat Protoc"},{"issue":"4","key":"3465_CR37","doi-asserted-by":"publisher","first-page":"1484","DOI":"10.1038\/s41596-020-0292-x","volume":"15","author":"M Efremova","year":"2020","unstructured":"Efremova M, Vento-Tormo M, Teichmann SA, Vento-Tormo R. CellPhoneDB: inferring cell-cell communication from combined expression of multi-subunit ligand-receptor complexes. Nat Protoc. 2020;15(4):1484\u2013506.","journal-title":"Nat Protoc"},{"issue":"6","key":"3465_CR38","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.cels.2015.12.004","volume":"1","author":"A Liberzon","year":"2015","unstructured":"Liberzon A, Birger C, Thorvaldsd\u00f3ttir H, Ghandi M, Mesirov JP, Tamayo P. The molecular signatures database (MSigDB) hallmark gene set collection. Cell Syst. 2015;1(6):417\u201325.","journal-title":"Cell Syst"},{"issue":"11","key":"3465_CR39","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1038\/nmeth.4463","volume":"14","author":"S Aibar","year":"2017","unstructured":"Aibar S, Gonz\u00e1lez-Blas CB, Moerman T, Huynh-Thu VA, Imrichova H, Hulselmans G, et al. SCENIC: single-cell regulatory network inference and clustering. Nat Methods. 2017;14(11):1083\u20136.","journal-title":"Nat Methods"},{"issue":"1","key":"3465_CR40","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1038\/s41392-023-01471-y","volume":"8","author":"L Sun","year":"2023","unstructured":"Sun L, Su Y, Jiao A, Wang X, Zhang B. T cells in health and disease. Signal Transduct Target Ther. 2023;8(1):235.","journal-title":"Signal Transduct Target Ther"},{"issue":"5","key":"3465_CR41","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1038\/s41423-020-0401-3","volume":"17","author":"HY Zheng","year":"2020","unstructured":"Zheng HY, Zhang M, Yang CX, Zhang N, Wang XC, Yang XP, et al. Elevated exhaustion levels and reduced functional diversity of T cells in peripheral blood May predict severe progression in COVID-19 patients. Cell Mol Immunol. 2020;17(5):541\u20133.","journal-title":"Cell Mol Immunol"},{"issue":"2","key":"3465_CR42","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1038\/s41577-018-0088-1","volume":"19","author":"SC Eisenbarth","year":"2019","unstructured":"Eisenbarth SC. Dendritic cell subsets in T cell programming: location dictates function. Nat Rev Immunol. 2019;19(2):89\u2013103.","journal-title":"Nat Rev Immunol"},{"issue":"1","key":"3465_CR43","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.cell.2020.11.025","volume":"184","author":"R Karki","year":"2021","unstructured":"Karki R, Sharma BR, Tuladhar S, Williams EP, Zalduondo L, Samir P, et al. Synergism of TNF-\u03b1 and IFN-\u03b3 triggers inflammatory cell death, tissue damage, and mortality in SARS-CoV-2 infection and cytokine shock syndromes. Cell. 2021;184(1):149\u201368.e17.","journal-title":"Cell"},{"issue":"7","key":"3465_CR44","doi-asserted-by":"publisher","first-page":"1671","DOI":"10.1016\/j.cell.2021.02.029","volume":"184","author":"JL Schultze","year":"2021","unstructured":"Schultze JL, Aschenbrenner AC. COVID-19 and the human innate immune system. Cell. 2021;184(7):1671\u201392.","journal-title":"Cell"},{"issue":"1","key":"3465_CR45","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1146\/annurev-immunol-082323-031642","volume":"43","author":"KE Traber","year":"2025","unstructured":"Traber KE, Mizgerd JP. The integrated pulmonary immune response to pneumonia. Annu Rev Immunol. 2025;43(1):545\u201369.","journal-title":"Annu Rev Immunol"},{"key":"3465_CR46","doi-asserted-by":"crossref","unstructured":"Xiao K, Cao Y, Yan P, Hu Y, Luu LDW, Pan P, et al. A large-scale single-cell atlas reveals the peripheral immune panorama of bacterial pneumonia. Am J Respir Crit Care Med. 2025;211(12):2363\u201381.","DOI":"10.1164\/rccm.202501-0217OC"},{"issue":"7","key":"3465_CR47","doi-asserted-by":"publisher","first-page":"1895","DOI":"10.1016\/j.cell.2021.01.053","volume":"184","author":"X Ren","year":"2021","unstructured":"Ren X, Wen W, Fan X, Hou W, Su B, Cai P, et al. COVID-19 immune features revealed by a large-scale single-cell transcriptome atlas. Cell. 2021;184(7):1895\u2013913.e19.","journal-title":"Cell"},{"issue":"18","key":"3465_CR48","doi-asserted-by":"publisher","first-page":"3882","DOI":"10.1016\/j.cell.2023.07.019","volume":"186","author":"JG Cheong","year":"2023","unstructured":"Cheong JG, Ravishankar A, Sharma S, Parkhurst CN, Grassmann SA, Wingert CK, et al. Epigenetic memory of coronavirus infection in innate immune cells and their progenitors. Cell. 2023;186(18):3882\u2013902.e24.","journal-title":"Cell"},{"issue":"1","key":"3465_CR49","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1038\/s41392-021-00526-2","volume":"6","author":"L Huang","year":"2021","unstructured":"Huang L, Shi Y, Gong B, Jiang L, Zhang Z, Liu X, et al. Dynamic blood single-cell immune responses in patients with COVID-19. Signal Transduct Target Ther. 2021;6(1):110.","journal-title":"Signal Transduct Target Ther"},{"issue":"3","key":"3465_CR50","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1038\/s41423-023-00974-6","volume":"20","author":"S Cambier","year":"2023","unstructured":"Cambier S, Gouwy M, Proost P. The chemokines CXCL8 and CXCL12: molecular and functional properties, role in disease and efforts towards pharmacological intervention. Cell Mol Immunol. 2023;20(3):217\u201351.","journal-title":"Cell Mol Immunol"},{"issue":"1","key":"3465_CR51","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1038\/nri.2015.7","volume":"16","author":"SM Man","year":"2016","unstructured":"Man SM, Kanneganti TD. Converging roles of caspases in inflammasome activation, cell death and innate immunity. Nat Rev Immunol. 2016;16(1):7\u201321.","journal-title":"Nat Rev Immunol"},{"issue":"9","key":"3465_CR52","doi-asserted-by":"publisher","first-page":"2128","DOI":"10.1038\/s41423-021-00728-2","volume":"18","author":"A P\u00e9rez-G\u00f3mez","year":"2021","unstructured":"P\u00e9rez-G\u00f3mez A, Vitall\u00e9 J, Gasca-Capote C, Gutierrez-Valencia A, Trujillo-Rodriguez M, Serna-Gallego A, et al. Dendritic cell deficiencies persist seven months after SARS-CoV-2 infection. Cell Mol Immunol. 2021;18(9):2128\u201339.","journal-title":"Cell Mol Immunol"},{"issue":"8","key":"3465_CR53","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1038\/s41590-023-01545-7","volume":"24","author":"FB Sulczewski","year":"2023","unstructured":"Sulczewski FB, Maqueda-Alfaro RA, Alc\u00e1ntara-Hern\u00e1ndez M, Perez OA, Saravanan S, Yun TJ, et al. Transitional dendritic cells are distinct from conventional DC2 precursors and mediate proinflammatory antiviral responses. Nat Immunol. 2023;24(8):1265\u201380.","journal-title":"Nat Immunol"},{"issue":"4","key":"3465_CR54","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1038\/s41590-025-02110-0","volume":"26","author":"G Canderan","year":"2025","unstructured":"Canderan G, Muehling LM, Kadl A, Ladd S, Bonham C, Cross CE, et al. Distinct type 1 immune networks underlie the severity of restrictive lung disease after COVID-19. Nat Immunol. 2025;26(4):595\u2013606.","journal-title":"Nat Immunol"},{"issue":"9","key":"3465_CR55","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1038\/s41577-020-0402-6","volume":"20","author":"Z Chen","year":"2020","unstructured":"Chen Z, John Wherry E. T cell responses in patients with COVID-19. Nat Rev Immunol. 2020;20(9):529\u201336.","journal-title":"Nat Rev Immunol"},{"key":"3465_CR56","unstructured":"Mathew D, Giles JR, Baxter AE, Oldridge DA, Greenplate AR, Wu JE, et al. Deep immune profiling of COVID-19 patients reveals distinct immunotypes with therapeutic implications. Science. 2020;369(6508):eabc8511."},{"issue":"5","key":"3465_CR57","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1038\/s41591-021-01329-2","volume":"27","author":"E Stephenson","year":"2021","unstructured":"Stephenson E, Reynolds G, Botting RA, Calero-Nieto FJ, Morgan MD, Tuong ZK, et al. Single-cell multi-omics analysis of the immune response in COVID-19. Nat Med. 2021;27(5):904\u201316.","journal-title":"Nat Med"},{"issue":"10","key":"3465_CR58","doi-asserted-by":"publisher","first-page":"1758","DOI":"10.1016\/j.stem.2021.07.001","volume":"28","author":"SB Larsen","year":"2021","unstructured":"Larsen SB, Cowley CJ, Sajjath SM, Barrows D, Yang Y, Carroll TS, et al. Establishment, maintenance, and recall of inflammatory memory. Cell Stem Cell. 2021;28(10):1758\u201374.e58.","journal-title":"Cell Stem Cell"},{"issue":"5","key":"3465_CR59","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1016\/S1473-3099(24)00670-4","volume":"25","author":"K Alves","year":"2025","unstructured":"Alves K, Kotloff K, McClelland RS, Kouassi A, Plested JS, Kalkeri R, et al. Immunogenicity and safety of a monovalent Omicron XBB.1.5 SARS-CoV-2 Recombinant Spike protein vaccine as a heterologous booster dose in US adults: interim analysis of a single-arm phase 2\/3 study. Lancet Infect Dis. 2025;25(5):585\u201394.","journal-title":"Lancet Infect Dis"},{"issue":"69","key":"3465_CR60","doi-asserted-by":"publisher","first-page":"eabo2202","DOI":"10.1126\/sciimmunol.abo2202","volume":"7","author":"CH GeurtsvanKessel","year":"2022","unstructured":"GeurtsvanKessel CH, Geers D, Schmitz KS, Mykytyn AZ, Lamers MM, Bogers S, et al. Divergent SARS-CoV-2 Omicron-reactive T and B cell responses in COVID-19 vaccine recipients. Sci Immunol. 2022;7(69):eabo2202.","journal-title":"Sci Immunol"},{"issue":"1","key":"3465_CR61","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/s41392-024-01751-1","volume":"9","author":"W Luo","year":"2024","unstructured":"Luo W, Gan J, Luo Z, Li S, Wang Z, Wu J, et al. Safety, immunogenicity and protective effectiveness of heterologous boost with a recombinant COVID-19 vaccine (Sf9 cells) in adult recipients of inactivated vaccines. Signal Transduct Target Ther. 2024;9(1):41.","journal-title":"Signal Transduct Target Ther"},{"issue":"10","key":"3465_CR62","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1038\/s41577-021-00592-1","volume":"21","author":"JS Tregoning","year":"2021","unstructured":"Tregoning JS, Flight KE, Higham SL, Wang Z, Pierce BF. Progress of the COVID-19 vaccine effort: viruses, vaccines and variants versus efficacy, effectiveness and escape. Nat Rev Immunol. 2021;21(10):626\u201336.","journal-title":"Nat Rev Immunol"},{"issue":"2","key":"3465_CR63","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.cmi.2021.10.005","volume":"28","author":"T Fiolet","year":"2022","unstructured":"Fiolet T, Kherabi Y, MacDonald CJ, Ghosn J, Peiffer-Smadja N. Comparing COVID-19 vaccines for their characteristics, efficacy and effectiveness against SARS-CoV-2 and variants of concern: a narrative review. Clin Microbiol Infect. 2022;28(2):202\u201321.","journal-title":"Clin Microbiol Infect"},{"issue":"1","key":"3465_CR64","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1038\/s41392-025-02132-y","volume":"10","author":"GJ Yang","year":"2025","unstructured":"Yang GJ, Lu M, Chen RR, Wang SQ, Wan S, Song XD, et al. Neutralizing antibody responses to three XBB protein vaccines in older adults. Signal Transduct Target Ther. 2025;10(1):48.","journal-title":"Signal Transduct Target Ther"},{"issue":"5","key":"3465_CR65","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1038\/nrd2289","volume":"6","author":"KL Jeffrey","year":"2007","unstructured":"Jeffrey KL, Camps M, Rommel C, Mackay CR. Targeting dual-specificity phosphatases: manipulating MAP kinase signalling and immune responses. Nat Rev Drug Discov. 2007;6(5):391\u2013403.","journal-title":"Nat Rev Drug Discov"},{"issue":"8080","key":"3465_CR66","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1038\/s41586-025-09332-0","volume":"645","author":"SB Chia","year":"2025","unstructured":"Chia SB, Johnson BJ, Hu J, Valen\u00e7a-Pereira F, Chadeau-Hyam M, Guntoro F, et al. Respiratory viral infections awaken metastatic breast cancer cells in lungs. Nature. 2025;645(8080):496\u2013506.","journal-title":"Nature"},{"issue":"21","key":"3465_CR67","doi-asserted-by":"publisher","first-page":"4615","DOI":"10.1016\/j.cell.2023.08.033","volume":"186","author":"S Yu","year":"2023","unstructured":"Yu S, Lin Y, Li Y, Chen S, Zhou L, Song H, et al. Systemic immune profiling of Omicron-infected subjects inoculated with different doses of inactivated virus vaccine. Cell. 2023;186(21):4615\u201331.e16.","journal-title":"Cell"},{"issue":"6284","key":"3465_CR68","doi-asserted-by":"publisher","first-page":"aaf1098","DOI":"10.1126\/science.aaf1098","volume":"352","author":"MG Netea","year":"2016","unstructured":"Netea MG, Joosten LA, Latz E, Mills KH, Natoli G, Stunnenberg HG, et al. Trained immunity: a program of innate immune memory in health and disease. Science. 2016;352(6284):aaf1098.","journal-title":"Science"},{"issue":"5","key":"3465_CR69","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1038\/s41588-023-01375-1","volume":"55","author":"R Edahiro","year":"2023","unstructured":"Edahiro R, Shirai Y, Takeshima Y, Sakakibara S, Yamaguchi Y, Murakami T, et al. Single-cell analyses and host genetics highlight the role of innate immune cells in COVID-19 severity. Nat Genet. 2023;55(5):753\u201367.","journal-title":"Nat Genet"},{"key":"3465_CR70","first-page":"359","volume":"400(10349)","author":"RECOVERY Collaborative Group","year":"2022","unstructured":"RECOVERY Collaborative Group. Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis. Lancet. 2022;400(10349):359\u201368.","journal-title":"Lancet"},{"issue":"6","key":"3465_CR71","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1016\/S2213-2600(25)00055-4","volume":"13","author":"A Amstutz","year":"2025","unstructured":"Amstutz A, Schandelmaier S, Ewald H, Speich B, Schwenke JM, Sch\u00f6nenberger CM, et al. Effects of Janus kinase inhibitors in adults admitted to hospital due to COVID-19: a systematic review and individual participant data meta-analysis of randomised clinical trials. Lancet Respir Med. 2025;13(6):530\u201344.","journal-title":"Lancet Respir Med"},{"issue":"16","key":"3465_CR72","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.1056\/NEJMoa2100433","volume":"384","author":"AC Gordon","year":"2021","unstructured":"Gordon AC, Mouncey PR, Al-Beidh F, Rowan KM, Nichol AD, Arabi YM, et al. Interleukin-6 receptor antagonists in critically ill patients with Covid-19. N Engl J Med. 2021;384(16):1491\u2013502.","journal-title":"N Engl J Med"},{"issue":"5","key":"3465_CR73","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1016\/S2213-2600(21)00081-3","volume":"9","author":"AS Soin","year":"2021","unstructured":"Soin AS, Kumar K, Choudhary NS, Sharma P, Mehta Y, Kataria S, et al. Tocilizumab plus standard care versus standard care in patients in India with moderate to severe COVID-19-associated cytokine release syndrome (COVINTOC): an open-label, multicentre, randomised, controlled, phase 3 trial. Lancet Respir Med. 2021;9(5):511\u201321.","journal-title":"Lancet Respir Med"},{"issue":"5","key":"3465_CR74","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1038\/s41590-025-02136-4","volume":"26","author":"F Keramati","year":"2025","unstructured":"Keramati F, Leijte GP, Bruse N, Grondman I, Habibi E, Ruiz-Moreno C, et al. Systemic inflammation impairs myelopoiesis and interferon type I responses in humans. Nat Immunol. 2025;26(5):737\u201347.","journal-title":"Nat Immunol"},{"issue":"12","key":"3465_CR75","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1038\/s41577-018-0066-7","volume":"18","author":"SA Jones","year":"2018","unstructured":"Jones SA, Jenkins BJ. Recent insights into targeting the IL-6 cytokine family in inflammatory diseases and cancer. Nat Rev Immunol. 2018;18(12):773\u201389.","journal-title":"Nat Rev Immunol"},{"issue":"21","key":"3465_CR76","doi-asserted-by":"publisher","first-page":"3857","DOI":"10.1016\/j.cell.2022.09.023","volume":"185","author":"RL Philips","year":"2022","unstructured":"Philips RL, Wang Y, Cheon H, Kanno Y, Gadina M, Sartorelli V, et al. The JAK-STAT pathway at 30: much learned, much more to do. Cell. 2022;185(21):3857\u201376.","journal-title":"Cell"},{"issue":"7","key":"3465_CR77","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1016\/j.immuni.2023.06.018","volume":"56","author":"R Savan","year":"2023","unstructured":"Savan R, Gale M Jr. Innate immunity and interferon in SARS-CoV-2 infection outcome. Immunity. 2023;56(7):1443\u201350.","journal-title":"Immunity"}],"container-title":["Respiratory Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12931-025-03465-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12931-025-03465-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12931-025-03465-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T13:03:22Z","timestamp":1770728602000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12931-025-03465-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,15]]},"references-count":77,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3465"],"URL":"https:\/\/doi.org\/10.1186\/s12931-025-03465-6","relation":{},"ISSN":["1465-993X"],"issn-type":[{"value":"1465-993X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,15]]},"assertion":[{"value":"5 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study protocol and procedures involving participants in the investigator-initiated trial (IIT) were reviewed and approved by the Ethics Committee of West China Hospital (Approval No.2023\u2009\u2212\u2009147, Registration number: ChiCTR2300067787). Written informed consent from all participants was obtained.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"53"}}